Ahmad Albshesh - Publications

Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn's disease-the MILESTONE-CD prospective cohort.

Journal: Journal of Crohn's & colitis

Published: August 05, 2026

Author's reply: "The "Duration-driven'' Exit strategy: Is time the ultimate predictor of sustained remission after biologic cessation?''.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 15, 2026

Author's reply: "A critical re-evaluation of the VEDUST-EXIT study: Beyond the headline relapse rate".

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 29, 2025

Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

Journal: Gastroenterology report

Published: September 18, 2025

Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 25, 2025